GL1X · GenesisL1 explorer

MolNFT v1 · #16242 · protein

Thrombin in complex with selective macrocyclic inhibitor

1NT1: “Thrombin in complex with selective macrocyclic inhibitor”. X-ray diffraction, 1 ligand (T76), 1 pocket (best druggability 0.56). MolNFT v1 #16242 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1NT1
Type
protein
Length
287 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thrombin; Hirudin
EC
3.4.21.5
UniProt
P00734, P28504
Ligands
T76
Pockets
1 · best druggability 0.56

Structure

x-ray diffraction · 2 distinct chains · 18% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThrombin (EC 3.4.21.5)protein27617% helix, 33% strandP00734
HHirudinprotein1136% helix, 0% strandP28504

Ligands and binding sites

  • T76 · (6r,21as)-17-chloro-6-cyclohexyl-2,3,6,7,10,11,19,20-octahydro-1H,5H-pyrrolo[1,2-k][1,4,8,11,14]benzoxatetraaza-cycloheptadecine-5,8,12,21(9h,13h,21ah)-tetrone · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12790.560.7642T76

Interfaces

1 interface between chains.

  • A–H · 680 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 modified (disulfide, sulfation).

Compared structures

  • 1NT1 · thrombin in complex with selective macrocyclic inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P28504 · AlphaFold monomer V2.0 prediction for hirudin-2 (P28504) · a predicted model of the same protein · chain H against A, TM-score 0.52

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.